In situ targeted activation of an anticancer agent using ultrasound-triggered release of composite droplets
- 1 December 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 142, 2-7
Abstract
No abstract availableKeywords
Funding Information
- LABEX WIFI (ANR-10-LABX-24, ANR-10-IDEX-0001-02 PSL*)
- Institut Pierre-Gilles de Gennes pour la microfluidique
- L’Oréal Unesco For Women in Science, Sport and Collection and La Ligue Nationale contre le Cancer (Comités Vienne and Deux-Sèvres)
This publication has 40 references indexed in Scilit:
- Supramolecular biomaterialsNature Materials, 2015
- Stimuli-responsive nanocarriers for drug deliveryNature Materials, 2013
- Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatmentDrug Design, Development and Therapy, 2013
- Crucial factors and emerging concepts in ultrasound-triggered drug deliveryJournal of Controlled Release, 2012
- New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: In-vivo characterizationJournal of Controlled Release, 2010
- Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomesChemistry and Physics of Lipids, 2009
- Drug loaded microbubble design for ultrasound triggered deliverySoft Matter, 2009
- Microbubbles in ultrasound-triggered drug and gene deliveryAdvanced Drug Delivery Reviews, 2008
- Driving delivery vehicles with ultrasoundAdvanced Drug Delivery Reviews, 2008
- Liposomes and Local Hyperthermia: Selective Delivery of Methotrexate to Heated TumorsScience, 1979